Differentiation Function Depending on the Stage of Mycophenolic Acid Differentially Impacts B Cell

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of Mycophenolic Acid in Patients with Lupus Nephritis

  2009cited by this paper
• Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid.

  2009cited by this paper
• Mycophenolic acid inhibits maturation and function of human dendritic cells and B cells.

  2009cited by this paper
• What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis?

  2009cited by this paper
• Effects of Immunosuppressive Drugs On Purified Human B Cells: Evidence Supporting the Use of MMF and Rapamycin

  2008cited by this paper
• The Immunosuppressor Mycophenolic Acid Kills Activated Lymphocytes by Inducing a Nonclassical Actin-Dependent Necrotic Signal1

  2008cited by this paper
• The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

  2008cited by this paper
• The role of IL‐21 in regulating B‐cell function in health and disease

  2008cited by this paper
• Mycophenolic Acid Activation of p53 Requires Ribosomal Proteins L5 and L11*

  2008cited by this paper
• Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study

  2008cited by this paper
• Mycophenolate mofetil promotes down-regulation of expanded B cells and production of TNF-alpha in an experimental murine model of colitis.

  2008cited by this paper
• Essential Role of IL-21 in B Cell Activation, Expansion, and Plasma Cell Generation during CD4+ T Cell-B Cell Collaboration1

  2007cited by this paper
• The Influence of Immunosuppressive Drugs on T- and B-cell Apoptosis via p53-Mediated Pathway In Vitro and In Vivo

  2006cited by this paper
• IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells

  2006cited by this paper
• Mechanisms of action of mycophenolate mofetil

  2005cited by this paper
• Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.

  2005cited by this paper
• IL-21 Induces Differentiation of Human Naive and Memory B Cells into Antibody-Secreting Plasma Cells1

  2005cited by this paper
• Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.

  2005cited by this paper
• Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl.

  2005cited by this paper
• The design and development of an immunosuppressive drug, mycophenolate mofetil

  2004cited by this paper
• Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.

  2004cited by this paper
• Differential Control of Cell Cycle, Proliferation, and Survival of Primary T Lymphocytes by Purine and Pyrimidine Nucleotides1

  2003cited by this paper
• Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children

  2003cited by this paper
• Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk

  2003cited by this paper
• Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells.

  2003cited by this paper
• Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells.

  2003cited by this paper
• Inosine monophosphate dehydrogenase (IMPDH) inhibition in vitro suppresses lymphocyte proliferation and the production of immunoglobulins, autoantibodies and cytokines in splenocytes from MRLlpr/lpr mice

  2001cited by this paper
• In vitro effects of mycophenolic acid on cell cycle and activation of human lymphocytes.

  2000cited by this paper
• Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis

  2000cited by this paper
• Coordinate Regulation of the IL-4, IL-13, and IL-5 Cytokine Cluster in Th2 Clones Revealed by Allelic Expression Patterns1

  2000cited by this paper
• Mycophenolate mofetil and its mechanisms of action.

  2000cited by this paper
• Mycophenolate mofetil ameliorates perivascular T lymphocyte inflammation and reduces the double-negative T cell population in SLE-prone MRLlpr/lpr mice.

  1999cited by this paper
• Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells.

  1999cited by this paper
• Differential regulation of antigen-induced IL-4 and IL-13 generation from T lymphocytes by IFN-alpha.

  1999cited by this paper
• Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn’s disease

  1998cited by this paper
• Clinical Pharmacokinetics of Mycophenolate Mofetil

  1998cited by this paper
• Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes.

  1998cited by this paper
• Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease.

  1997cited by this paper
• Mycophenolic acid suppresses protein N-linked glycosylation in human monocytes and their adhesion to endothelial cells and to some substrates.

  1996cited by this paper
• Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil.

  1996cited by this paper
• Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts.

  1996cited by this paper
• A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage.

  1996cited by this paper
• Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expression.

  1994cited by this paper
• Mycophenolic Acid and Some Antioxidants Induce Differentiation of Monocytic Lineage Cells and Augment Production of the IL‐1 Receptor Antagonist

  1993cited by this paper
• Characterization of human type I and type II IMP dehydrogenases.

  1993cited by this paper
• Therapy of rheumatoid arthritis with mycophenolate mofetil.

  1993cited by this paper
• Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells.

  1992cited by this paper
• Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety.

  1987cited by this paper

• No citing papers are available for this paper.